One platform, every evidence use case
Whether you run outcomes research across a health system, deliver regulatory-grade studies as a CRO, or prove a product's real-world impact, Augura produces defensible evidence in weeks. Six core use cases, one connected, expert-supervised workflow.
Real-world evidence at scale
For health systems and research teams running RWE and outcomes research across large populations. Profile real-world cohorts, map outcomes, and surface the causal chain — not correlation, causation — across many studies without adding headcount.
Causal inference · Outcomes research · Population-scale RWE · Reproducible cohorts
Peer-reviewed, publishable studies
For academic medical centers and consultancies that need output which survives peer review. Publishable studies in weeks instead of years, with your team's name on the paper and every assumption traceable and IRB-ready.
Peer-reviewed publications · IRB-ready protocols · Full traceability · Scientific credibility
Regulatory-grade evidence & reproducibility
For CROs and regulated teams. PMCF-grade evidence aligned with FDA and EU MDR, reproducible end-to-end and audit-ready, with standardized output formats for regulatory dossiers and submissions.
PMCF-grade · FDA & EU MDR · Audit-ready · Standardized submission formats
Data standardization & governance
For teams losing expert hours to messy, inconsistent input data. Augura maps data to a consistent evidence model, runs compliance and quality triage from the first upload, and standardizes variables — so your statisticians analyze instead of clean.
Variable mapping · Compliance triage · Local, secure processing · Data-quality reports
Payer & market-access evidence
Health-economics models and real-world outcomes that get products onto reimbursement lists and support hospital procurement and HTA submissions — the case payers accept.
Health economics · Reimbursement dossiers · HTA-ready · Market access
Commercial & investment evidence
For MedTech, digital health and pharma proving impact to win deals, justify premium pricing, and strengthen valuation. Evidence packages for sales, tenders, fundraises, and M&A. (This is where the former startup ICP now lives — present but secondary.)
Commercial evidence · Competitive proof · Investor packages · M&A readiness
